| FRI-516-YI Aurora kinase A and programmed death-ligand 1: expression dynamics in hepatocellular carcinoma development and the regulatory role of the kinase in immune checkpoint … L Grisetti, AA Saponaro, C Sukowati, D Bonazza, E Giacomello, P Tarchi, ... Journal of Hepatology 80, S429-S430, 2024 | | 2024 |
| The role of Aurora kinase A in hepatocellular carcinoma: Unveiling the intriguing functions of a key but still underexplored factor in liver cancer L Grisetti, CJC Garcia, AA Saponaro, C Tiribelli, D Pascut Cell Proliferation, e13641, 2024 | | 2024 |
| Proteome profiling identifies circulating biomarkers associated with hepatic steatosis in subjects with Prader-Willi syndrome D Pascut, PJ Giraudi, C Banfi, S Ghilardi, C Tiribelli, A Bondesan, D Caroli, ... Frontiers in Endocrinology 14, 1254778, 2023 | | 2023 |
| Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma care IMC Aquino, D Pascut Annals of Hepatology, 101176, 2023 | 4 | 2023 |
| Clinical Significance of Apurinic/Apyrimidinic Endodeoxyribonuclease 1 and MicroRNA Axis in Hepatocellular Carcinoma G Mangiapane, D Pascut, E Dalla, G Antoniali, M Degrassi, LS Crocè, ... Journal of Clinical and Translational Hepatology 11 (6), 1291, 2023 | 5 | 2023 |
| The expression of Aurora Kinase A and its potential role as a regulator of Programmed Death-Ligand 1 in hepatocellular carcinoma: Implications for immunotherapy and immune … L Grisetti, AA Saponaro, CHC Sukowati, P Tarchi, LS Crocè, S Palmisano, ... Digestive and Liver Disease 55, S219-S220, 2023 | 2 | 2023 |
| Bilirubin-Induced transcriptomic imprinting in neonatal hyperbilirubinemia JP Llido, E Fioriti, D Pascut, M Giuffrè, C Bottin, F Zanconati, C Tiribelli, ... Biology 12 (6), 834, 2023 | 4 | 2023 |
| Bilirubin-Induced Transcriptomic Imprinting in Neonatal Hyperbilirubinemia. Biology 2023, 12, 834 JP Llido, E Fioriti, D Pascut, M Giuffrè, C Bottin, F Zanconati, C Tiribelli, ... | 1 | 2023 |
| MiR-3201 as a prognostic blood biomarker for curative treatments in hepatocellular carcinoma L Grisetti, NVT Võ, NNQ Nguyễn, LS Crocè, A Visintin, C Tiribelli, ... Technology in cancer research & treatment 21, 15330338221132924, 2022 | 4 | 2022 |
| Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals LKD Cabral, L Grisetti, MY Pratama, C Tiribelli, D Pascut Cancers 14 (11), 2700, 2022 | 4 | 2022 |
| Recent hints on the dual role of discs large MAGUK scaffold protein 5 in cancers and in hepatocellular carcinoma C Andolfi, C Tiribelli, D Pascut Frontiers in Bioscience-Landmark 27 (5), 164, 2022 | 5 | 2022 |
| MicroRNAs related to TACE treatment response: a review of the literature from a radiological point of view AM Bozzato, P Martingano, RA Pozzi Mucelli, MFM Cavallaro, ... Diagnostics 12 (2), 374, 2022 | 10 | 2022 |
| HCV Proteins modulate the host cell miRNA expression contributing to Hepatitis C pathogenesis and Hepatocellular Carcinoma Development D Pascut, M Hoang, NNQ Nguyen, MY Pratama, C Tiribelli Cancers 13 (10), 2485, 2021 | 20 | 2021 |
| The role of microRNAs in the cisplatin-and radio-resistance of cervical cancer R Masadah, S Rauf, MY Pratama, C Tiribelli, D Pascut Cancers 13 (5), 1168, 2021 | 29 | 2021 |
| Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients E Gurian, A Di Silvestre, E Mitri, D Pascut, C Tiribelli, M Giuffrè, LS Crocè, ... Analytical and bioanalytical chemistry 413, 1303-1312, 2021 | 39 | 2021 |
| Circulating long and circular noncoding RNA as non-invasive diagnostic tools of hepatocellular carcinoma CHC Sukowati, LKD Cabral, C Tiribelli, D Pascut Biomedicines 9 (1), 90, 2021 | 33 | 2021 |
| The Role of microRNAs in the Cisplatin-and Radio-Resistance of Cervical Cancer. Cancers 2021, 13, 1168 R Masadah, S Rauf, MY Pratama, C Tiribelli, D Pascut s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 1 | 2021 |
| Circulating Long and Circular Noncoding RNA as Non-Invasive Diagnostic Tools of Hepatocellular Carcinoma. Biomedicines 2021, 9, 90 CHC Sukowati, LKD Cabral, C Tiribelli, D Pascut s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 1 | 2021 |
| Weighted miRNA co-expression networks analysis identifies circulating miRNA predicting overall survival in hepatocellular carcinoma patients D Pascut, MY Pratama, F Gilardi, M Giuffrè, LS Crocè, C Tiribelli Scientific reports 10 (1), 18967, 2020 | 22 | 2020 |
| Circulatory miRNA as a biomarker for therapy response and disease-free survival in hepatocellular carcinoma MY Pratama, A Visintin, LS Crocè, C Tiribelli, D Pascut Cancers 12 (10), 2810, 2020 | 23 | 2020 |
Claudio TiribelliFondazione Italiana Fegato FIF - Italian Liver Foundation - University of Trieste在 fegato.it 的电子邮件经过验证
